SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001445305-14-005105
Filing Date
2014-11-13
Accepted
2014-11-13 16:18:45
Documents
9
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kindred10qq-32014.htm 10-Q 510057
2 EXHIBIT 31.1 exhibit311q32014.htm EX-31.1 13208
3 EXHIBIT 32.1 exhibit321q32014.htm EX-32.1 6621
  Complete submission text file 0001445305-14-005105.txt   3396194

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT kin-20140930.xml EX-101.INS 545668
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kin-20140930.xsd EX-101.SCH 20257
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kin-20140930_cal.xml EX-101.CAL 42214
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kin-20140930_def.xml EX-101.DEF 85436
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kin-20140930_lab.xml EX-101.LAB 271452
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kin-20140930_pre.xml EX-101.PRE 148334
Mailing Address 58 WEST PORTAL AVE., #105 SAN FRANCISCO CA 94127
Business Address 58 WEST PORTAL AVE., #105 SAN FRANCISCO CA 94127 415-596-1557
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36225 | Film No.: 141218677
SIC: 2834 Pharmaceutical Preparations